BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 18467645)

  • 1. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
    Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
    Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
    Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
    Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
    Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
    Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
    Bouallegue A; Vardatsikos G; Srivastava AK
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells.
    Yogi A; Callera GE; Montezano AC; Aranha AB; Tostes RC; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1960-7. PubMed ID: 17569879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells.
    Touyz RM; Yao G; Schiffrin EL
    Can J Physiol Pharmacol; 2005 Jan; 83(1):91-7. PubMed ID: 15759055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
    Yang M; Kahn AM
    Am J Hypertens; 2006 Jun; 19(6):587-92. PubMed ID: 16733230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.
    Touyz RM; Yao G; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):981-7. PubMed ID: 12663375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
    Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
    Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
    Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells.
    Rautureau Y; Paradis P; Schiffrin EL
    Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
    Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
    Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR.
    Sandoval YH; Li Y; Anand-Srivastava MB
    Cell Signal; 2011 Nov; 23(11):1716-26. PubMed ID: 21712088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
    Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
    J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells.
    Gomez Sandoval YH; Lévesque LO; Anand-Srivastava MB
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1037-45. PubMed ID: 20029540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.